The most expensive samples are the ones you can’t use.

Accelerate time-to-revenue with unified sample data.

Built for and trusted by high-growth biopharmas scaling translational programs, QuartzBio Sample Intelligence is the upstream data foundation that delivers confidence in every readout. Ensure every sample is usable, every dataset is complete, and every readout happens on time with unified sample data.

Schedule a 15-min executive walkthrough to see the impact for your trials.

Schedule My Walkthrough

Sample data bottlenecks are delaying your readouts—and your next milestone.

Translational leaders at growing biopharmas face a critical risk: data fragmentation slows decisions and puts program timelines at risk.

  • Unusable samples drive costly rework
  • Data bottlenecks delay analysis timelines
  • Incomplete datasets weaken decision confidence
  • Fragmentation increases regulatory and portfolio risk

The science may be sound, but the data infrastructure isn’t. Budgets get drained. Funding slows.

Not a LIMS; not another data integration layer. Sample Intelligence proactively detects and resolves data quality issues before they disrupt your pipeline.

What translational leaders gain with QuartzBio Sample Intelligence:

  • Faster readouts, fewer delays
    Ensure samples arrive analysis-ready with complete, usable data.
  • Fewer unusable samples
    Eliminate rework and maximize every sample’s value.
  • Traceable, decision-ready datasets
    Complete metadata and traceability for confident regulatory and scientific decisions.
  • Real-time visibility into sample risk across your program
    Track sample usability, risks, and progress across studies.

If you’re ready to fix data quality problems at their source and regain confidence in your conclusions, explore Sample Intelligence.

QuartzBio Sample Intelligence - Automated Unification of Sample Ecosystem
Watch a demo

Case Study: How a top biopharma increased trial capacity and eliminated hidden data loss

“With QuartzBio, we spend 85% less time on sample-related tasks.”
–Top Biopharma

A top biopharma discovered that outdated sample ops workflows were putting their pipeline at risk. With QuartzBio, they eliminated fragmented systems and gained full visibility into sample data—accelerating timelines and improving dataset quality.

  • 100% consent documentation visibility with linked sample and consent data

  • 100% detection of missing samples — zero silent losses

  • 80% less rework by catching integrity issues upstream

  • Fewer biomarker exclusions due to metadata gaps or consent issues

View Case Study

Give your pipeline a solid data foundation before it’s too late.

In 15 minutes, identify the bottlenecks slowing your readouts and see how to ensure every sample contributes to a complete, decision-ready dataset.

Identify the biggest risks in your data ecosystem:

Schedule My 15-min Executive Walkthrough
QuartzBio Logo White May 2026

QuartzBio is the only company purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, our solutions transform fragmented data into actionable intelligence, enabling conversational insights into your unified ecosystem of sample, clinical, and biomarker data.

QUARTZBIO® is a registered trademark of Precision Regulatory and Translational Sciences, Inc., dba QuartzBio,  in the United States and/or other jurisdictions. All rights reserved.

© 2026 QuartzBio.
All rights reserved.
Privacy Notice
Ethics & Third-Party Notice